HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma - Concepedia

Concepedia

Publication | Closed Access

HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma

32

Citations

22

References

2010

Year

Colin A. Purdie, Lee B. Jordan, J. McCullough, Sharon Edwards, Joan E. Cunningham, Miriam Walsh, A Grant, Norman Pratt, Alastair M. Thompson

Abstract

CB11 immunohistochemistry accurately predicts HER2 amplification status and can be reliably carried out on core biopsy specimens of breast carcinoma.

References

	Year	Citations

Page 1